What Is Victoza Pen – Liraglutide Injection?

Victoza Pen – Liraglutide Injection is a prescription medication used to manage blood sugar levels in people with type 2 diabetes. The active ingredient liraglutide belongs to the class of medications known as GLP-1 receptor agonists, which help regulate glucose metabolism and appetite.

Victoza is administered using a pre-filled injection pen and is typically taken once daily at any time of the day.

Doctors usually prescribe Victoza as part of a comprehensive diabetes management plan, which may include:

• Balanced and controlled diet

• Regular physical activity

• Blood glucose monitoring

• Additional diabetes medications if necessary

Each Victoza pen contains 18 mg of liraglutide solution and can deliver doses of 0.6 mg, 1.2 mg, or 1.8 mg depending on the prescribed treatment plan.

In addition to improving blood sugar control, Victoza may also reduce the risk of major cardiovascular events such as heart attack or stroke in adults with type 2 diabetes and existing heart disease.

How Victoza Pen – Liraglutide Injection Works

Liraglutide improves blood sugar regulation through several biological mechanisms.

1. GLP-1 Receptor Activation

Liraglutide mimics the GLP-1 hormone, which helps regulate insulin secretion and appetite control.

2. Increased Insulin Secretion

The medication stimulates the pancreas to release insulin when blood glucose levels increase.

3. Reduced Glucagon Production

Victoza lowers the release of glucagon, a hormone that raises blood sugar by stimulating glucose production in the liver.

4. Slower Gastric Emptying

The medication slows stomach emptying, which:

• reduces rapid glucose absorption

• stabilizes post-meal blood sugar

• increases satiety

5. Appetite Regulation

Liraglutide may influence appetite centers in the brain, which can help support weight management in some patients.

Indications

A healthcare professional may prescribe Victoza Pen – Liraglutide Injection for:

• Type 2 diabetes mellitus management

• Improving glycemic control in adults and children (10 years and older)

• Reducing cardiovascular risk in certain patients with diabetes

• Supporting metabolic health alongside lifestyle modifications

Victoza is not intended for treating type 1 diabetes.

Usage & Administration

Important: Always follow instructions provided by your healthcare professional.

Typical clinical guidance includes:

• Inject once daily

• Administer under the skin (subcutaneous injection)

• Common injection sites include abdomen, thigh, or upper arm

• Rotate injection sites regularly

The medication can be taken with or without food.

Early-stage semaglutide therapy programs often begin with Wegovy Weight Loss Pen 0.25 Mg before gradual dose escalation.

Typical Dosing Progression

Treatment often begins with a lower dose to reduce gastrointestinal side effects.

Typical dosing may include:

• 0.6 mg once daily (starting dose)

• Increase to 1.2 mg once daily

• May increase to 1.8 mg once daily if additional control is required

Your healthcare provider will determine the appropriate dosage.

Special population treatment guidance is supported by clinical standards published by WHO – Neglected Tropical Disease Programs.

Safety Information & Precautions

Before using Victoza, inform your healthcare provider if you have:

• History of thyroid cancer

• Multiple endocrine neoplasia syndrome type 2

• Pancreatitis history

• Kidney disease

• Severe gastrointestinal disorders

Important safety considerations include:

• Use under medical supervision

• Monitor blood glucose regularly

• Follow the prescribed dose schedule

• Do not exceed recommended dosage

Higher-dose semaglutide therapy such as Wegovy FlexTouch Pen 1.7 Mg may be used within advanced weight-management treatment plans.

Possible Side Effects

Many people tolerate liraglutide therapy well, though side effects may occur.

Common Side Effects

• Nausea

• Vomiting

• Diarrhea

• Decreased appetite

• Indigestion

• Constipation

Less Common Side Effects

• Headache

• Fatigue

• Mild dizziness

• Injection-site reactions

Rare but Serious Reactions

Seek medical attention if you experience:

• Severe abdominal pain

• Symptoms of pancreatitis

• Allergic reactions

• Persistent vomiting

Storage Instructions

Store Victoza Pen – Liraglutide Injection according to manufacturer guidelines.

Typical storage recommendations include:

• Store unused pens in a refrigerator at 2°C–8°C

• Do not freeze the medication

• After first use, store at 15°C–30°C or refrigerated

• Use the pen within 30 days after first use

  FAQs